Raziel Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Raziel Therapeutics General Information
Description
Manufacturer of injectable drugs designed to decrease submental fat and fat disorders. The company offers a single injection treatment into subcutaneous fat that causes immediate fat cell death at the injection site, enabling healthcare professionals to provide patients with a significant treatment fat reduction for long periods without any invasive procedures.
Contact Information
Website
www.raziel-therapy.comCorporate Office
- 10 Prof. Menachem Plaut Street
- Rehovot 7670621
- Israel
Corporate Office
- 10 Prof. Menachem Plaut Street
- Rehovot 7670621
- Israel
Raziel Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Oct-2025 | Completed | Clinical Trials - Phase 3 | |||
| 6. Secondary Transaction - Private | 20-Mar-2020 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC (Series C) | 18-Dec-2019 | Completed | Clinical Trials - Phase 3 | |||
| 4. Early Stage VC (Series A) | 25-Feb-2016 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 10-Jul-2015 | Completed | Clinical Trials - Phase 3 | |||
| 2. Seed Round | 01-Dec-2014 | $600K | $1.19M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC | 03-Dec-2012 | $589K | $589K | Completed | Clinical Trials - Phase 1 |
Raziel Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred C | ||||||||
| Preferred B2 | ||||||||
| Preferred B1 | ||||||||
| Preferred A2 | ||||||||
| Preferred A1 | 25,000 | $16.67 | $16.67 | 1x | $16.67 | 2.61% | ||
| Preferred A | 75,000 | $7.59 | $7.59 | 1x | $7.59 | 3.91% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Raziel Therapeutics Patents
Raziel Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023378681-A1 | Crystalline carbazole derivative and methods of making thereof | Pending | 07-Nov-2022 | ||
| EP-4615443-A1 | Crystalline carbazole derivative and methods of making thereof | Pending | 07-Nov-2022 | ||
| EP-4615443-A4 | Crystalline carbazole derivative and methods of making thereof | Pending | 07-Nov-2022 | ||
| WO-2024100533-A1 | Crystalline carbazole derivative and methods of making thereof | Inactive | 07-Nov-2022 | ||
| AU-2022320006-A1 | Compositions and methods for treating lipoma pain | Inactive | 28-Jul-2021 | A61K31/403 |
Raziel Therapeutics Signals
Raziel Therapeutics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yissum | Accelerator/Incubator | Minority | ||
| Catalyst Investments | PE/Buyout | Minority | ||
| China Everbright | Asset Manager | Minority | ||
| Peregrine Ventures | Venture Capital | Minority | ||
| Wille Finance | Family Office | Minority |
Raziel Therapeutics FAQs
-
When was Raziel Therapeutics founded?
Raziel Therapeutics was founded in 2012.
-
Where is Raziel Therapeutics headquartered?
Raziel Therapeutics is headquartered in Rehovot, Israel.
-
What is the size of Raziel Therapeutics?
Raziel Therapeutics has 7 total employees.
-
What industry is Raziel Therapeutics in?
Raziel Therapeutics’s primary industry is Drug Discovery.
-
Is Raziel Therapeutics a private or public company?
Raziel Therapeutics is a Private company.
-
What is Raziel Therapeutics’s current revenue?
The current revenue for Raziel Therapeutics is .
-
How much funding has Raziel Therapeutics raised over time?
Raziel Therapeutics has raised $29.3M.
-
Who are Raziel Therapeutics’s investors?
Yissum, Catalyst Investments, China Everbright, Peregrine Ventures, and Wille Finance are 5 of 11 investors who have invested in Raziel Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process